Emergent BioSolutions | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
ALKERMES USD 399.81M 108.66M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amarin USD 119.52M 1.51M 2025-03
ANI Pharmaceuticals USD 149.8M 4.94M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Exact Sciences USD 6.11M 773K 2025-03
Exelixis USD 183.75M 33.62M 2025-04
Glaxosmithkline GBP 3.87B 678M 2024-12
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Ironwood Pharmaceuticals USD 88.56M 348K 2024-12
Lonza CHF 1.11B 286M 2024-12
Merck USD 8.63B 4.61B 2025-03
Moderna USD 1.62B 304M 2025-03
Myriad Genetics USD 91.8M 10.6M 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Pacira USD 283.61M 6.84M 2025-03
Pfizer USD 1.43B 387M 2025-03
PTC Therapeutics USD 2.03B 1.25B 2025-03
Sanofi 7.99B 550M 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
United Therapeutics USD 1.9B 202.7M 2025-03


Emergent BioSolutions Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.